SOURCE: Infocast

April 20, 2007 17:02 ET

Impacts of BARDA and OPHEMC's Plan on Biodefense Countermeasures to Be Hot Topic at 5th Annual Biodefense Vaccines & Therapeutics Conference

LOS ANGELES, CA -- (MARKET WIRE) -- April 20, 2007 -- Special Assistant to the President for Biodefense Rajeev Venkayya will give the Keynote Address on government efforts to accelerate the development of biodefense medical countermeasures at Infocast 5th annual Biodefense Vaccines & Therapeutics Conference, to be held in Washington, DC June 4 - 6, 2007.

In light of shifting governmental funding priorities and strategic acquisition plans for biodefense vaccines, therapeutics and other medical countermeasures, this up-to-the-minute discussion is sure to be informative.

Key government representatives tasked with building our biodefense capacity will provide detailed information on their agencies' strategies and programs. Speakers from the Department of Homeland Security (DHS), Department of Health and Human Services (DHHS), Food and Drug Administration (FDA), National Institutes of Allergy and Infectious Diseases (NIAID), Defense Advanced Research Projects Agency (DARPA), Defense Threat Reduction Agency (DTRA), and Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD) will be on hand to provide insights on the latest developments.

These senior representatives will discuss:

-- Funding priorities and strategic plans

-- Impact of the Biomedical Advanced Research Development Agency (BARDA)

-- Overview of the Office of Public Health Emergency Medical Countermeasure's (OPHEMC) plans for acquiring biodefense countermeasures

-- Research and funding opportunities at the DOD and NIAID

-- Opportunities for greater industry participation

The Conference is the ideal venue for participants seeking a role in the national biodefense effort to interact face-to-face with government representatives, and get the most up to date information on shifting funding requirements and program priorities for biodefense.

In addition, the Conference's Networking Fair will provide a forum for government, biotechnology/pharmaceutical companies, research institutions and universities to explore opportunities for partnership and collaboration.

The Conference also features an insightful scientific symposium, Late Stage Vaccines and Therapeutics Development, where leading biodefense researchers from government, academia and industry will provide an update on the latest R&D efforts and advances.

For further information about the Biodefense Vaccines & Therapeutics Conference, please visit or call Alfredo Alcantar at (818) 888-4445 ext. 31

About Infocast

Infocast is an event production company with twenty years of successful industry experience. The Biodefense Vaccines & Therapeutics conference series has brought together senior government representatives, key biotechnology and pharmaceutical companies, research contractors, institutes and universities, and the public health community to address the need for biodefense medical countermeasures.